SFCM
ASMB icon

Seven Fleet Capital Management’s Assembly Biosciences ASMB Stock Holding History

Seven Fleet Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
56,147
-17,615
-24% -$502K 0.49% 47
2025
Q4 		$2.51M Buy
+73,762
New +$2.38M 1.7% 9

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Seven Fleet Capital Management's ASMB Position: Q1 2026 in Review

Seven Fleet Capital Management reduced its Assembly Biosciences (ASMB) stake by 24% in Q1 2026, selling an estimated $502K and leaving 56,147 shares worth $1.56M. The position accounts for 0.49% of the portfolio, ranked #47.

Seven Fleet Capital Management first reported a position in ASMB in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.51M in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Seven Fleet Capital Management held 56,147 shares of Assembly Biosciences worth $1.56M as of Q1 2026.
  • Seven Fleet Capital Management sold 17,615 Assembly Biosciences shares in Q1 2026, an estimated $502K.
  • Assembly Biosciences made up 0.49% of Seven Fleet Capital Management's portfolio in Q1 2026, its #47 holding.
  • Seven Fleet Capital Management first reported a position in Assembly Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Assembly Biosciences position peaked at $2.51M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.